buyWeak
Shah Capital Management bought $435k of SOL
CHAIRMAN at Emeren Group Ltd. 187,096 shares at an average of $2.32, traded Nov 27, 2023, filed Nov 29, 2023.
Conviction score
37Value
$435k
187,096 shares
Holdings after
17,888,038
+1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +17Trade size$435k at market
- 0Relative to holdingsHoldings up 1.1%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001383838-23-000018, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 27, 2023 | POpen-market purchase American Depositary Sharesindirect: Refer to Footnote 3 | +153,431 | $2.33 | $357k | 17,854,373 | Nov 29, 2023 |
| Nov 28, 2023 | POpen-market purchase American Depositary Sharesindirect: See Footnote 3 | +33,665 | $2.30 | $77k | 17,888,038 | Nov 29, 2023 |
Related signals
Other insiders at Emeren Group Ltd and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $30k 16,853 shares | +0% | |
| 25Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $104k 58,921 shares | +0% | |
| 45Moderate | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $1.4M 596,118 shares | +3% | |
| 31Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $379k 155,070 shares | +1% | |
| 35Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $617k 268,014 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.